Moderna released full data on its closely watched cancer vaccine developed with Merck.
Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful advance in melanoma ...
Stéphane Bancel defended his melanoma data and argued that rivals can’t easily copy the technology. | World News ...
AI-generated illustration Moderna's stock fell more than 1% following disappointing market reactions to data from its latest ...
Leaked data from Moderna Inc. and Merck & Co.’s highly anticipated melanoma vaccine trial has led to a rare disconnect ...
Moderna shares are taking a hit after the leak of highly anticipated details about the company’s vaccine for the skin cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results